Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Peakman

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Transplantation|February 1, 1994
Development of techniques for obtaining monodispersed human islet cellsM Peakman, G L McNab, N D Heaton, et al.
Clinical Immunology and Immunopathology|November 1, 1996
Abnormalities of CD45 isoform expression in HIV infectionM Mahalingam, A Pozniak, T J McManus, et al.
Annals of the Rheumatic Diseases|March 1, 1990
Antireticulin antibody in systemic sclerosisT Mahmud, M Peakman, G Senaldi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1994
An investigation of antibodies to nerve growth factor in diabetic autonomic neuropathyM M Zanone, J P Banga, M Peakman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2007
Immune responses to myelin proteins in Guillain-Barré syndromeA Makowska, J Pritchard, L Sanvito, et al.
Clinical and Experimental Immunology|September 1, 1993
T cell activation and disease severity in HIV infectionM Mahalingam, M Peakman, E T Davies, et al.
Tissue Antigens|August 27, 2014
Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06M Eichmann, A de Ru, P A van Veelen, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Markers of immune cell activation and disease progression. Cell activation in HIV diseaseM Peakman, M Mahalingam, A Pozniak, et al.
Diabetologia|April 10, 2003
Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II moleculesT P Astill, R J Ellis, S Arif, et al.
The Journal of Infectious Diseases|December 1, 1990
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severityG Senaldi, M Peakman, T McManus, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Transplantation|February 1, 1994
Development of techniques for obtaining monodispersed human islet cellsM Peakman, G L McNab, N D Heaton, et al.
Clinical Immunology and Immunopathology|November 1, 1996
Abnormalities of CD45 isoform expression in HIV infectionM Mahalingam, A Pozniak, T J McManus, et al.
Annals of the Rheumatic Diseases|March 1, 1990
Antireticulin antibody in systemic sclerosisT Mahmud, M Peakman, G Senaldi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1994
An investigation of antibodies to nerve growth factor in diabetic autonomic neuropathyM M Zanone, J P Banga, M Peakman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2007
Immune responses to myelin proteins in Guillain-Barré syndromeA Makowska, J Pritchard, L Sanvito, et al.
Clinical and Experimental Immunology|September 1, 1993
T cell activation and disease severity in HIV infectionM Mahalingam, M Peakman, E T Davies, et al.
Tissue Antigens|August 27, 2014
Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06M Eichmann, A de Ru, P A van Veelen, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Markers of immune cell activation and disease progression. Cell activation in HIV diseaseM Peakman, M Mahalingam, A Pozniak, et al.
Diabetologia|April 10, 2003
Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II moleculesT P Astill, R J Ellis, S Arif, et al.
The Journal of Infectious Diseases|December 1, 1990
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severityG Senaldi, M Peakman, T McManus, et al.
Pageof 14